Mountain Group Capital
Mountain Group Capital is a Nashville-based venture capital firm investing in early-stage life sciences (diagnostics, animal health) and disruptive technology companies, anchoring Series A-C rounds with active board governance and operator-led support from a four-partner managing director bench.
- Company typePrivate
- Founded2002
- HeadquartersNashville, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Mountain Group Capital does
Mountain Group Capital (legally Mountain Group Partners) is a Nashville, Tennessee-based venture capital firm founded in 1999 that invests in early-stage life sciences and disruptive technology companies. The firm concentrates capital in three core verticals: diagnostics (Castle Biosciences, Mindera Health, PinkDx, Circular Genomics), animal health (TARGAN, Vytelle, Airvet, Exubrion, Advanced Animal Diagnostics, In the Bowl), and selective biotech or disruptive tech (AN2 Therapeutics, Clearside Biomedical, Silicon Ranch, Ethos). As of the latest disclosures, the team comprises nine professionals including four Managing Directors and supports a portfolio of more than 40 companies.
The firm makes direct equity investments, typically anchoring or co-leading Series A through Series C rounds, and maintains active board seats through partner participation. Revenue is generated via standard venture fund economics: 2% management fees on committed capital (the active vehicle, MGP Venture Fund III, closed at $128 million in June 2022) and 20% carried interest on realized exits. Distribution of capital occurs through direct investment with active board governance rather than traditional sales channels, and deal flow originates primarily from industry referrals and the partners' domain networks.
Mountain Group Capital differentiates through operator-led diligence: Managing Director Joe Cook Jr. is the former Group VP of Global Operations at Eli Lilly and former CEO/Chairman of Amylin Pharmaceuticals (sold to Bristol-Myers Squibb for $5.3 billion); Managing Director Rob Readnour spent nearly 30 years at Elanco Animal Health in senior R&D roles; and Managing Director Byron Smith held senior executive positions at Asurion, Verizon, and Procter & Gamble. Realized exits include the Castle Biosciences IPO (NASDAQ: CSTL, 2018), Clearside Biomedical IPO (NASDAQ: CLSD, 2016), G1 Therapeutics IPO (NASDAQ: GTHX, 2017), and the 2026 sale of TARGAN to Merck Animal Health.
Mountain Group Capital firmographics
Firmographics- Name
- Mountain Group Capital
- Legal name
- Mountain Group Partners
- Website
- https://mtngp.com/
- Company type
- Private
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Mountain Group Capital is a Nashville-based venture capital firm investing in early-stage life sciences (diagnostics, animal health) and disruptive technology companies, anchoring Series A-C rounds with active board governance and operator-led support from a four-partner managing director bench.
- Ownership category
- akta.pro rank
Mountain Group Capital industry classification
Industry- Product category
- Venture Capital
- NAICS
- Portfolio Management and Investment Advice (523940), Portfolio Management and Investment Advice (52394)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)
Keywords
Where Mountain Group Capital is headquartered
LocationHeadquarters
- HQ city
- Nashville
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Mountain Group Capital business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Others
Revenue model
- Venture Capital Fund Management: The firm manages venture capital funds (MGP Venture Fund III at $128 million) and generates returns through equity investments in portfolio companies. Revenue comes from management fees and carried interest on successful exits.
Go-to-market motion2 records
Distribution channels1 record
Marketing channels3 records
Mountain Group Capital product offering
Product offeringCore offering
Mountain Group Capital is a Nashville-based venture capital firm that invests in early-stage healthcare and technology companies, with particular focus on diagnostics, animal health, life sciences, and disruptive technologies. The firm manages multi-stage venture funds (including MGP Venture Fund III) and provides active board participation, strategic guidance, and operational support to portfolio companies across the company lifecycle.
Product overview
Mountain Group Capital (Mountain Group Partners) is a Nashville-based venture capital firm that invests in healthcare and technology companies. The firm focuses on four main sectors: Diagnostics (including molecular testing and precision medicine companies like Circular Genomics, Mindera Health, and PinkDx), Animal Health (companion animal and livestock health companies including TARGAN, Airvet, and Vytelle), Other Life Sciences (biopharmaceutical companies like AN2 Therapeutics and Clearside Biomedical), and Disruptive Technologies (including renewable energy through Silicon Ranch and training platforms like Ethos). As a venture capital investor, Mountain Group Capital does not develop or sell its own products; rather, it holds equity stakes in portfolio companies that offer diverse diagnostic tests, therapeutic treatments, animal health products, telehealth platforms, renewable energy solutions, and AI-driven healthcare technologies.
Differentiator
Problem solved
Functional benefit
Products and services
- MGP Venture Fund III A multi-stage venture capital fund managed by Mountain Group Capital that invests in early-stage healthcare and technology companies across diagnostics, animal health, life sciences, and disruptive technologies; offered to Limited Partners as a committed-capital fund vehicle.
Quantifiable outcome
- Multiple portfolio companies have achieved successful exits including IPOs and acquisitions (Castle Biosciences IPO, Amylin sold for $5.3B to Bristol-Myers Squibb, TARGAN sold to Merck Animal Health)
- +2 more outcomes
Companies that use Mountain Group Capital
Customer profileNamed customers8 records
Segments5 records
Ideal customer profiles2 records
Mountain Group Capital technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability1 record
Mountain Group Capital partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core, strategic and flagship.
- AirvetcoreHealthy Paws partnered with Airvet to make veterinary care more accessible via telehealth.
- Lilly Gateway LabsstrategicCircular Genomics joined Lilly Gateway Labs in San Diego to develop its circular RNA platform for diagnosis and prognosis of Alzheimer's disease.
- National Psoriasis FoundationcoreMindera Health partnered with National Psoriasis Foundation to advance precision medicine in psoriasis treatment.
- Trouw Nutrition North AmericacoreTARGAN secured first international placement with Trouw Nutrition North America for its novel vaccine delivery system.
- Wayne-Sanderson FarmscoreTARGAN and Wayne-Sanderson Farms announced pioneering commercial collaboration for poultry vaccine delivery.
- Silicon RanchflagshipMGP has partnered with Silicon Ranch for more than a decade, playing crucial roles in critical strategic moments and providing insightful strategic advice.
Scale indicators4 records
Recent moves10 records
Expansion highlights5 records
Mountain Group Capital competitors and assessment
Company assessmentDirect peers
- ARCH Venture Partners: Long-tenured venture capital firm investing in early-stage biotechnology, diagnostics, and platform technologies. Shares deep-science orientation and long-duration investment model with MGP.
- Longitude Capital: Healthcare-focused venture capital firm investing in innovative medical products and healthcare services. Comparable mid-market healthcare VC orientation with similar active-investment philosophy.
- Hatteras Venture Partners: Durham, NC-based early-stage venture capital firm focused on healthcare and life sciences, with a similar size, sector focus, and active board-participation model. Directly comparable to MGP in fund size, vertical specialization, and target stage.
- Frazier Healthcare Partners: Seattle-based healthcare-focused venture capital firm investing across diagnostics, therapeutics, and digital health. Comparable in life sciences vertical focus and active approach to portfolio company building.
- Versant Ventures: Healthcare-focused venture capital firm investing in biotech, medical devices, and healthcare services. Shares diagnostics and therapeutics specialization with MGP, though operates at a larger fund scale.
- Pappas Ventures: Durham, NC-based life sciences venture capital firm investing in therapeutics, diagnostics, and medical devices. Comparable in regional positioning, sector focus, and early-stage orientation.
- 5AM Ventures: Early-stage venture capital firm focused on life sciences, including biotech, medical devices, and diagnostics. Comparable in stage focus, sector specialization, and hands-on portfolio company engagement.
Broad incumbents
- OrbiMed: One of the largest healthcare-dedicated investment firms globally, with deep presence in therapeutics, medical devices, and diagnostics. Operates as a broader incumbent in the same healthcare VC space MGP occupies.
Regional players
- Council Capital: Nashville-based private equity firm investing in healthcare services and technology. Regional peer with overlapping healthcare focus and operating partnership model, though typically at growth rather than venture stage.
- Innova Memphis: Memphis-based early-stage venture capital firm operating in the Southeastern U.S. with comparable regional reach and focus on healthcare and technology investments.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Mountain Group Capital social profiles
Digital presenceMountain Group Capital financial estimates
Financial estimateRevenue estimate
Valuation estimate
Mountain Group Capital leadership team
Management profileNumber of profiles
Profiles1 record
Mountain Group Capital funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Mountain Group Capital M&A and investment
M&A and investmentM&A
Investments68 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Mountain Group Capital
What does Mountain Group Capital do?
Mountain Group Capital is a Nashville-based venture capital firm that invests in early-stage healthcare and technology companies, with particular focus on diagnostics, animal health, life sciences, and disruptive technologies. The firm manages multi-stage venture funds (including MGP Venture Fund III) and provides active board participation, strategic guidance, and operational support to portfolio companies across the company lifecycle.
Is Mountain Group Capital a public or private company?
Mountain Group Capital is a private company. It is classified as family owned and is currently operating.
When was Mountain Group Capital founded?
Mountain Group Capital was founded in 2002. It employs 1 to 10 people.
Where is Mountain Group Capital based?
Mountain Group Capital is headquartered in Nashville, United States, in the North America region.
How does Mountain Group Capital make money?
One revenue line is on record: venture Capital Fund Management.
Who are Mountain Group Capital's main competitors?
Direct peers on record are ARCH Venture Partners, Longitude Capital, Hatteras Venture Partners, Frazier Healthcare Partners, Versant Ventures, Pappas Ventures and 5AM Ventures. OrbiMed is listed as a broad incumbent. Regional players are Council Capital and Innova Memphis.
Does Mountain Group Capital have an API?
No public API is recorded for Mountain Group Capital.
What industry is Mountain Group Capital in?
Mountain Group Capital's product category is Venture Capital. Its primary akta.pro industry code is FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists). Its NAICS code is 523940 and its SIC code is 6282.